Consonance Capital Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-887,885	Closed	-$37.7M	–	21
2021 Q2	$37.7M	Sell	887,885 -2,324	-0.3%	-$98.7K	4.54%	7
2021 Q1	$54.8M	Buy	890,209 +333,114	+60%	+$20.5M	5.84%	5
2020 Q4	$39.3M	Buy	+557,095	New	+$39.3M	3.67%	11